# Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated Cirrhosis

> **NCT03855956** · NA · COMPLETED · sponsor: **Kaleido Biosciences** · enrollment: 40 (actual)

## Conditions studied

- Early Cirrhosis

## Interventions

- **OTHER:** KB174
- **OTHER:** Maltodextrin

## Key facts

- **NCT ID:** NCT03855956
- **Lead sponsor:** Kaleido Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-27
- **Primary completion:** 2019-10-01
- **Final completion:** 2019-10-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03855956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03855956, "Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated Cirrhosis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03855956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*